Navigation Links
Kensey Nash to Present at the Jefferies 3rd Annual Healthcare Conference
Date:6/10/2009

EXTON, Pa., June 10 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the Jefferies 3rd Annual Healthcare Conference on Thursday, June 18, 2009.

Joseph W. Kaufmann, Kensey Nash's President & CEO, will deliver the Company's presentation, beginning at approximately 9:00 a.m. (ET). To hear the live webcast of the Kensey Nash presentation go to http://www.wsw.com/webcast/jeff35/knsy/. The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 9:00 a.m. (ET) on Thursday, June 18, 2009.

About Kensey Nash Corporation. Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, including sports medicine, spine, and endovascular. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.


'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Kensey Nash to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
2. Kensey Nash Reports Third Quarter and First Nine Month Fiscal Year 2009 Results
3. Kensey Nash Corporation Announces Its Third Quarter 2009 Earnings Release Date and Teleconference
4. Kensey Nash Announces 600,000 Share Stock Repurchase Program
5. Kensey Nash to Participate in the Sidoti Thirteenth Annual New York Emerging Growth Institutional Investor Forum Conference
6. Kensey Nash Announces Appointment of Chief Financial Officer
7. Kensey Nash to Present at the Canaccord Adams Musculoskeletal Conference
8. Kensey Nash Announces Director Resignation
9. Kensey Nash Corporation Announces Its Second Quarter 2009 Earnings Release Date and Teleconference
10. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
11. Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2008 Earnings Release Date and Teleconference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... Antonio, TX (PRWEB) , ... April 24, 2017 , ... ... by the glitterati, those unreal icons inhabiting the rarified air of pop and film ... the paparazzi and anyone snapping pictures: the smile. Grins now run the gamut from ...
(Date:4/24/2017)... Calif. (PRWEB) , ... April 24, 2017 , ... The ... $1.6 million in charitable dental services to 1,961 people during the April 22-23 event ... at no charge to Californians who experience barriers to care, CDA Cares educates the ...
(Date:4/24/2017)... ... 24, 2017 , ... Veteran Theresa James awoke to the sound of her ... In “Healing Tears,” James depicts every parent’s worst nightmare, when her three children were ... conversations and situations throughout my divorce,” James said. “After the death of my children, ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... variety of unique liquid food supplements, announced its popular products are now available ... , ALP Nutrition® prioritizes the use of premium natural ingredients in making ...
(Date:4/24/2017)... ... 2017 , ... My T Chai, a South African company that creates a ... on RevNutrition.com, a popular website specializing in sales of nutritional products. , Chai ... and Siam. It spread across Asia and Africa quickly, and today recipes vary from ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... , April 18, 2017 Research and Markets ... 2017-2021" report to their offering. ... The global arthroscopy devices market to grow at a CAGR ... Global Arthroscopy Devices Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
Breaking Medicine Technology: